Clinical Study

Low Serum Concentration of Obestatin as a Predictor of Mortality in Maintenance Hemodialysis Patients

Table 4

Clinical and biochemical characteristics in 94 prevalent hemodialysis patients, according to obestatin and TNFα 1.

Low TNF-α ( )High TNF-α ( )MANOVA2
Low Ob. ( )High Ob. ( )Low Ob. ( )High Ob. ( )

Obestatin (ng/mL)
Age (Y) NS
Gender (men %)3616079 52 O, T, O × T
Log vintage (mo) NS
DM (%)357.14052.6 51.9NS
CVD(%)346.46057.944.4NS
DEI (kcal/kg/d) NS
DPI (g/kg/d) NS
nPNA (g/kg/d) NS
Albumin (g/L) NS
Log IL-6 (pg/mL) NS
Log leptin (ng/mL) NS
BMI (kg/m2) NS
FMI (kg/m2) O
FFMI (kg/m2) NS
ECW/TBW NS

The low obestatin or TNFα group was defined as obestatin < 7.12 ng/mL or TNFα < 17.75 pg/mL values below the median of distribution.
Two-factor MANOVA. Significant ( ) effects are given for obestatin (O), TNFα (T), and the interaction obestatin with TNF-α (O × T).
Continuous variables that did not follow a normal distribution (dialysis vintage, interleukin-6, and leptin) were log transformed before their insertion in this model.
Assessed by test.
TNF-α: tumor necrosis factor-α; Ob: obestatin; DM: diabetes mellitus; CVD: cardiovascular disease in the past; DEI: daily energy intake; DPI: daily protein intake; nPNA: normalized protein nitrogen appearance; IL-6: interleukin-6; BMI: body mass index; ECW/TBW: extracellular water to total body water ratio; FMI: fat mass index; FFMI: fat-free mass index.